Penn Radiology Oncologic Imaging Essentials


Session 1: Head and Neck

Viral-Induced Neoplasia of the Head and Neck Laurie A. Loevner, MD
Laryngeal Cancer: What the Clinician Needs to Know Laurie A. Loevner, MD
PET/CT in Head and Neck Cancer: Pearls and Pitfalls Laurie A. Loevner, MD
TI-RADS and Thyroid Cancer Detection Jill Langer, MD
Orbital Neoplasia Patterns of SpreadĀ  Laurie A. Loevner, MD
Robotics in Head and Neck Cancer: Emphasis on Oropharyngeal Cancer Laurie A. Loevner, MD

Session 2: Body Imaging I: Abdomen and Prostate

Imaging of Upper GI Tract Tumors Susan L. Summerton, MD
Imaging of GU Tract Malignancies Susan L. Summerton, MD
Incidentalomas on Abdominal Imaging Susan L. Summerton, MD
Prostate Cancer Update Jill Langer, MD

Session 3: Breast

Digital Breast Tomosynthesis: Today and Tomorrow Samantha P. Zuckerman, MD
Update on Screening MR - Not Just for BRCA PatientsĀ  Samantha P. Zuckerman, MD
Management of High Risk Breast Lesions Samantha P. Zuckerman, MD
Imaging Special Populations Samantha P. Zuckerman, MD
Challenging Cases in Breast Imaging Samantha P. Zuckerman, MD

Session 4: Body Imaging II: GYN and Colonography

Non-Ovarian GYN Malignancy- What Role Does the Radiologist Play? Jill Langer, MD
Ovarian Cancer Screening Jill Langer, MD
Screening for Colon Cancer: Role of CT Colonograpy Susan L. Summerton, MD
Pre- and Post-Operative Imaging of the Colon Susan L. Summerton, MD

Session 5: Nuclear Medicine Indications and Applications

Accepted Indications for FDG PET/CT Daniel A. Pryma, MD
Pearls and Pitfalls in FDG PET/CT Daniel A. Pryma, MD
FDG PET/CT in Response Assessment: Solid Tumors, Lymphoma, and Immunotherapy Daniel A. Pryma, MD
Beyond FDG: PET/CT with Ga-68 DOTATATE, F-18 Fluciclovine, and PSMA Daniel A. Pryma, MD
The Role of Nuclear Medicine in Thyroid Disease Daniel A. Pryma, MD
Challenging Nuclear Medicine Cases Daniel A. Pryma, MD

End